Stockreport

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients [Yahoo! Finance]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF implanted mechanical circulatory support device, has the potential to improve the time in therapeutic range a factor correlated in the ARIES-HM3 trial with better patien [Read more]